Trial Profile
Uninterrupted Clopidogrel Therapy Before Elective Colonoscopy Will Increase the Risk of Post-polypectomy Bleeding
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Feb 2019
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary)
- Indications Embolism and thrombosis
- Focus Adverse reactions; Pharmacogenomic
- 29 Jan 2019 Status changed from active, no longer recruiting to completed.
- 25 Oct 2018 Results published in the Gastroenterology
- 07 May 2018 Planned End Date changed from 1 Dec 2017 to 1 Oct 2018.